Results 21 to 30 of about 294,466 (353)

Antibiotic Susceptibility Profile of Pseudomonas aeruginosa Canine Isolates from a Multicentric Study in Romania

open access: yesAntibiotics, 2021
Treating infections caused by Pseudomonas aeruginosa is increasingly difficult due to high antibiotic resistance, materialized through the presence of multiple resistance strains, as well as due to rapid development of resistance throughout treatment ...
János Dégi   +6 more
doaj   +1 more source

A Systematic Review of Human Infections by Pseudomonas mendocina

open access: yesTropical Medicine and Infectious Disease, 2020
Pseudomonas mendocina is a Gram-negative, rod-shaped, aerobic bacterium that belongs in the family Pseudomonadaceae and has been isolated from water and soil.
Petros Ioannou, Georgios Vougiouklakis
doaj   +1 more source

The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach [PDF]

open access: yes, 2010
We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
A. G. O'DONNELL   +6 more
core   +1 more source

Les infections à Pseudomonas aeruginosa au service des maladies infectieuses du CHU YO, Burkina Faso: à propos deux cas

open access: yesThe Pan African Medical Journal, 2015
Nous rapportons deux cas d'infection à Pseudomonas aeruginosa: un cas de méningite et un cas d'infection urinaire. Les auteurs rappellent qu'à côté des étiologies classiques des méningites et des infections urinaires, des germes résistants comme ...
Savadogo Mamoudou   +2 more
doaj   +1 more source

LasB, ExoS and Nan1 genes as potential predictors of site-specific Pseudomonas aeruginosa pathogenicity in nosocomial isolates [PDF]

open access: yesMicrobes and Infectious Diseases
Background: Pseudomonas aeruginosa is an opportunistic pathogen that represents a global public health threat. Immunocompromised hosts and cystic fibrosis patients are primarily susceptible to high morbidity and mortality due to pulmonary tract ...
Maii Shams Eldeen   +4 more
doaj   +1 more source

In Vitro Inhibition Zone Test Of Binahong (Anredera Cordifolia) Towards Staphylococcus Aureus, Enterococcus Faecalis, Escherichia Coli, And Pseudomonas Aeruginosa [PDF]

open access: yes, 2012
This is a true experimental research with post test-only control group design. The study was conducted to test the inhibitory zone of the Binahong leaf extract (Anredera cordifolia) against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli ...
Amertha, I. (IBPM)   +2 more
core   +2 more sources

Using a phenotypic method to confirm the presence of the efflux pump associated with resistance to ciprofloxacin in Pseudomonas aeruginosa isolated from skin samples [PDF]

open access: yesبیولوژی کاربردی, 2019
Introduction One of the most important causes of nosocomial infections in patients with skin infections is Pseudomonas aeruginosa. The occurrence of antibiotic resistance with various mechanisms is one of the problems in treating these patients.
Ali Rahmati, Mohammad Reza zolfaghary
doaj  

Evaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan [PDF]

open access: yesExploration of Medicine
Aim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy.
Savana Sobh   +3 more
doaj   +1 more source

Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections

open access: yesAntibiotics, 2023
Human Pseudomonas infections have high morbidity and mortality rates. Pseudomonas bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a multidrug-resistant phenotype.
Giuseppe Pipitone   +10 more
doaj   +1 more source

Pseudomonas infection in CF [PDF]

open access: yesThorax, 2000
Elborn et al 1 have attempted to address the important question of whether it is better to treat patients with cystic fibrosis (CF) who have chronic Pseudomonas aeruginosa infection with intravenous antibiotics on the basis of symptoms or to treat them electively, and found no significant difference between their groups.
Rob Roseby, John Massie
openaire   +2 more sources

Home - About - Disclaimer - Privacy